<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37156398</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>299</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Intrinsic structural vulnerability in the hydrophobic core induces species-specific aggregation of canine SOD1 with degenerative myelopathy-linked E40K mutation.</ArticleTitle><Pagination><StartPage>104798</StartPage><MedlinePgn>104798</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104798</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2023.104798</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(23)01826-4</ELocationID><Abstract><AbstractText>Canine degenerative myelopathy (DM), a fatal neurodegenerative disease in dogs, shares clinical and genetic features with amyotrophic lateral sclerosis, a human motor neuron disease. Mutations in the SOD1 gene encoding Cu/Zn superoxide dismutase (SOD1) cause canine DM and a subset of inherited human amyotrophic lateral sclerosis. The most frequent DM causative mutation is homozygous E40K mutation, which induces the aggregation of canine SOD1 but not of human SOD1. However, the mechanism through which canine E40K mutation induces species-specific aggregation of SOD1 remains unknown. By screening human/canine chimeric SOD1s, we identified that the humanized mutation of the 117th residue (M117L), encoded by exon 4, significantly reduced aggregation propensity of canine SOD1<sup>E40K</sup>. Conversely, introducing a mutation of leucine 117 to methionine, a residue homologous to canine, promoted E40K-dependent aggregation in human SOD1. M117L mutation improved protein stability and reduced cytotoxicity of canine SOD1<sup>E40K</sup>. Furthermore, crystal structural analysis of canine SOD1 proteins revealed that M117L increased the packing within the hydrophobic core of the &#x3b2;-barrel structure, contributing to the increased protein stability. Our findings indicate that the structural vulnerability derived intrinsically from Met 117 in the hydrophobic core of the &#x3b2;-barrel structure induces E40K-dependent species-specific aggregation in canine SOD1.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan; Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Seiji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan; Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: swtnb@riem.nagoya-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akutsu</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Keio University, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muraki</LastName><ForeName>Norifumi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Keio University, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamishina</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Life Science Research Center, Gifu University, Gifu, Japan; Kyoto AR Advanced Veterinary Medical Center, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Keio University, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan; Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan. Electronic address: koji.yamanaka@riem.nagoya-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004283" MajorTopicYN="Y">Dog Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cu/Zn superoxide dismutase (SOD1)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">degenerative myelopathy (DM)</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">protein chimera</Keyword><Keyword MajorTopicYN="N">protein stability</Keyword><Keyword MajorTopicYN="N">protein structure</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37156398</ArticleId><ArticleId IdType="pmc">PMC10248865</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2023.104798</ArticleId><ArticleId IdType="pii">S0021-9258(23)01826-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) J.&#xa0;Biol. Chem. 1969;244:6049&#x2013;6055.</Citation><ArticleIdList><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S.L., Tolwani R.J., Varma S., Quignon P., Galibert F., Cork L.C. Structure, chromosomal location, and analysis of the canine Cu/Zn superoxide dismutase (SOD1) gene. J.&#xa0;Hered. 2002;93:119&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">12140271</ArticleId></ArticleIdList></Reference><Reference><Citation>Tainer J.A., Getzoff E.D., Beem K.M., Richardson J.S., Richardson D.C. Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. J.&#xa0;Mol. Biol. 1982;160:181&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">7175933</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernethy J.L., Steinman H.M., Hill R.L. Bovine erythrocyte superoxide dismutase. Subunit structure and sequence location of the intrasubunit disulfide bond. J.&#xa0;Biol. Chem. 1974;249:7339&#x2013;7347.</Citation><ArticleIdList><ArticleId IdType="pubmed">4436313</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Carr&#xec; M.T. Lessons from models of SOD1-linked familial ALS. Trends Mol. Med. 2004;10:393&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">15310460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004;27:723&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 2001;8:933&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno M.S., Bosco D.A. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell. Neurosci. 2013;7:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.S., Dokholyan N.V. SOD1 oligomers in amyotrophic lateral sclerosis. Curr. Opin. Struct. Biol. 2021;66:225&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965251</ArticleId><ArticleId IdType="pubmed">33465527</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates J.R., Wininger F.A. Canine degenerative myelopathy. Vet. Clin. North Am. Small Anim. Pract. 2010;40:929&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">20732599</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T., Johnson G.S., Wade C.M., Katz M.L., Johnson G.C., Taylor J.F., et al. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009;106:2794&#x2013;2799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wininger F.A., Zeng R., Johnson G.S., Katz M.L., Johnson G.C., Bush W.W., et al. Degenerative myelopathy in a bernese mountain dog with a novel SOD1 missense mutation. J.&#xa0;Vet. Intern. Med. 2011;25:1166&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">21848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivansson E.L., Megquier K., Kozyrev S.V., Mur&#xe9;n E., K&#xf6;rberg I.B., Swofford R., et al. Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy. Proc. Natl. Acad. Sci. U. S. A. 2016;113:E3091&#x2013;E3100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896683</ArticleId><ArticleId IdType="pubmed">27185954</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng R., Coates J.R., Johnson G.C., Hansen L., Awano T., Kolicheski A., et al. Breed distribution of SOD1 alleles previously associated with canine degenerative myelopathy. J.&#xa0;Vet. Intern. Med. 2014;28:515&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4238831</ArticleId><ArticleId IdType="pubmed">24524809</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp M.J., Beckett J., Coates J.R., Miller T.M. Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model. Exp. Neurol. 2013;248:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3773294</ArticleId><ArticleId IdType="pubmed">23707216</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Montague P., Loney C., Campbell C., Shafie I.N.F., Anderson T.J., et al. In&#xa0;vitro evidence consistent with an interaction between wild-type and mutant SOD1 protein associated with canine degenerative myelopathy. Eur. J. Neurosci. 2019;50:3896&#x2013;3905.</Citation><ArticleIdList><ArticleId IdType="pubmed">31336405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobatake Y., Sakai H., Tsukui T., Yamato O., Kohyama M., Sasaki J., et al. Localization of a mutant SOD1 protein in E40K-heterozygous dogs: implications for non-cell-autonomous pathogenesis of degenerative myelopathy. J.&#xa0;Neurol. Sci. 2017;372:369&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">27838005</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange R.W., Antonyuk S.V., Hough M.A., Doucette P.A., Valentine J.S., Hasnain S.S. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J.&#xa0;Mol. Biol. 2006;356:1152&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">16406071</ArticleId></ArticleIdList></Reference><Reference><Citation>Crown A.M., Roberts B.L., Crosby K., Brown H., Ayers J.I., Hart P.J., et al. Experimental mutations in superoxide dismutase 1 provide insight into potential mechanisms involved in aberrant aggregation in familial amyotrophic lateral sclerosis. G3 (Bethesda) 2019;9:719&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404617</ArticleId><ArticleId IdType="pubmed">30622123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Kamatari Y.O., Kuwahara Y., Hara H., Yamato O., Maeda S., et al. Canine SOD1 harboring E40K or T18S mutations promotes protein aggregation without reducing the global structural stability. PeerJ. 2020;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7368427</ArticleId><ArticleId IdType="pubmed">32742795</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004;22:1302&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B., Barreau A., Rohatgi R. Phase separation-deficient TDP43 remains functional in splicing. Nat. Commun. 2019;10:4890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814767</ArticleId><ArticleId IdType="pubmed">31653829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Takei Y.I., Ohara S., Fujiwara N., Hozumi I., Furukawa Y. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Mol. neurodegener. 2019;14:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6862823</ArticleId><ArticleId IdType="pubmed">31744522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart P.J. Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr. Opin. Chem. Biol. 2006;10:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">16516535</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 2003;10:461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">12754496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart P.J., Liu H., Pellegrini M., Nersissian A.M., Gralla E.B., Valentine J.S., et al. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci. 1998;7:545&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2143953</ArticleId><ArticleId IdType="pubmed">9541385</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipp E.L., Cantini F., Bertini I., Valentine J.S., Banci L. Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis. Biochemistry. 2003;42:1890&#x2013;1899.</Citation><ArticleIdList><ArticleId IdType="pubmed">12590575</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Nomura T., Ohara S., Watanabe S., Yamanaka K., Morisaki Y., et al. A&#xa0;copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:2119&#x2013;2130.</Citation><ArticleIdList><ArticleId IdType="pubmed">29551730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J.&#xa0;Biol. Chem. 2003;278:5984&#x2013;5992.</Citation><ArticleIdList><ArticleId IdType="pubmed">12458194</ArticleId></ArticleIdList></Reference><Reference><Citation>Monera O.D., Sereda T.J., Zhou N.E., Kay C.M., Hodges R.S. Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helix. J.&#xa0;Pept. Sci. 1995;1:319&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">9223011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandberg W.S., Terwilliger T.C. Influence of interior packing and hydrophobicity on the stability of a protein. Science. 1989;245:54&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">2787053</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B.Y., Zhou N.E., Kay C.M., Hodges R.S. Packing and hydrophobicity effects on protein folding and stability: effects of beta-branched amino acids, valine and isoleucine, on the formation and stability of two-stranded alpha-helical coiled coils/leucine zippers. Protein Sci. 1993;2:383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2142373</ArticleId><ArticleId IdType="pubmed">8453376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tych K.M., Batchelor M., Hoffmann T., Wilson M.C., Hughes M.L., Paci E., et al. Differential effects of hydrophobic core packing residues for Thermodynamic and mechanical stability of a Hyperthermophilic protein. Langmuir. 2016;32:7392&#x2013;7402.</Citation><ArticleIdList><ArticleId IdType="pubmed">27338140</ArticleId></ArticleIdList></Reference><Reference><Citation>Tompa D.R., Kadhirvel S. Changes in hydrophobicity mainly promotes the aggregation tendency of ALS associated SOD1 mutants. Int. J. Biol. Macromol. 2020;145:904&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">31669277</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson J., Mu X., Lang L., Wang H., Binolfi A., Theillet F.X., et al. Thermodynamics of protein destabilization in live cells. Proc. Natl. Acad. Sci. U. S. A. 2015;112:12402&#x2013;12407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4603463</ArticleId><ArticleId IdType="pubmed">26392565</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S.D., Ding F., Dokholyan N.V. Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis. J.&#xa0;Mol. Biol. 2003;334:515&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">14623191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamae S., Kobatake Y., Suzuki R., Tsukui T., Kato S., Yamato O., et al. Accumulation and aggregate formation of mutant superoxide dismutase 1 in canine degenerative myelopathy. Neuroscience. 2015;303:229&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162235</ArticleId></ArticleIdList></Reference><Reference><Citation>Motohashi K. A&#xa0;simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis. BMC Biotechnol. 2015;15:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4453199</ArticleId><ArticleId IdType="pubmed">26037246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Hayakawa T., Wakasugi K., Yamanaka K. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death Dis. 2014;5:e1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237269</ArticleId><ArticleId IdType="pubmed">25356866</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Inami H., Oiwa K., Murata Y., Sakai S., Komine O., et al. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43. Cell Death Dis. 2020;11:909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585435</ArticleId><ArticleId IdType="pubmed">33097688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishino K., Watanabe S., Shijie J., Murata Y., Oiwa K., Komine O., et al. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway. Acta Neuropathol. Commun. 2019;7:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6657153</ArticleId><ArticleId IdType="pubmed">31345270</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajiri M., Aoki H., Shintani A., Sue K., Akashi S., Furukawa Y. Metal distribution in Cu/Zn-superoxide dismutase revealed by native mass spectrometry. Free Radic. Biol. Med. 2022;183:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">35314356</ArticleId></ArticleIdList></Reference><Reference><Citation>WADDELL W.J. A&#xa0;simple ultraviolet spectrophotometric method for the determination of protein. J.&#xa0;Lab. Clin. Med. 1956;48:311&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">13346201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C., Li Y., Yates E.A., Fernig D.G. SimpleDSFviewer: a tool to analyze and view differential scanning fluorimetry data for characterizing protein thermal stability and interactions. Protein Sci. 2020;29:19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933846</ArticleId><ArticleId IdType="pubmed">31394001</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., et al. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W. Xds. Acta Crystallogr. D Biol. Crystallogr. 2010;66:125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815665</ArticleId><ArticleId IdType="pubmed">20124692</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011;67:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Skubak P., Pannu N.S. Automatic protein structure solution from weak X-ray data. Nat. Commun. 2013;4:2777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3868232</ArticleId><ArticleId IdType="pubmed">24231803</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., et al. Phenix: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Linding R., Schymkowitz J., Rousseau F., Diella F., Serrano L. A&#xa0;comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J.&#xa0;Mol. Biol. 2004;342:345&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">15313629</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau F., Schymkowitz J., Serrano L. Protein aggregation and amyloidosis: confusion of the kinds? Curr. Opin. Struct. Biol. 2006;16:118&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauchere J.-L., Pliska V. Hydrophobic parameters pi of amino-acid side chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med. Chem. 1983;18:369&#x2013;375.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>